Psychometric Evaluation in Patients With Brain Damage During Neuroinflammation

Launched by NEUROMED IRCCS · Jul 7, 2022

Keywords

ClinConnect Summary

The presence of a damage to the central and / or peripheral nervous system resulting from diseases of a different nature (such as, Multiple Sclerosis, Parkinson's disease, dementia, head trauma, stroke, epilepsy or other neurological syndromes) is commonly cause of both physical than mental disability. The presence of cognitive deficits in the sphere of memory or language is often evident at a first clinical examination. However, the evaluation of certain domains such as mood disorders, behavior, sleep-wake cycle or eating habits, may be less evident, even if they have a very strong impact ...

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Presence of brain damage resulting from: Multiple Sclerosis, Parkinson's Disease, Dementia, head trauma, neurosurgery, Stroke, Epilepsy or other neurological syndromes (for the experimental group only);
• • Be able to perform the tests to be administered for the duration of the study;
• • Patients must be able to follow protocol directions throughout the study;
• • Patients must be able to understand the purpose of the study;
• • Signature of informed consent, approved by our Ethics Committee.
• Exclusion Criteria:
• • Inability, even partial, to understand and want;
• • Patients with other pathologies that in the opinion of the scientific responsible prevent their recruitment